Aspen could produce 10-million dexamethasone tablets within a month, CEO says

Results from a trial showed that dexamethasone reduced death rates by about a third

WATCH: Can Aspen meet demand for its Covid-19 drug?

Aspen CEO Stephen Saad talks to Business Day TV about the company’s capacity to meet the growing demand for life-saving medication

Aspen shares jump to highest since January 2019 on Covid-19 treatment breakthrough

The pharmaceutical manufacturer is a leading global supplier of dexamethasone, which trials show cuts the risk of death among some Covid-19 patients

BL PREMIUM
Aspen notes results of Covid-19 trial using a drug it has rights to

The drug maker has rights to dexamethasone, with preliminary results of a trial in the UK showing it can be life-saving for some Covid-19 patients

Ascendis CFO Kieron Futter to step down in September

The announcement comes days after the group said it had successfully negotiated an extension of its debt payments

Life Healthcare reports hacking attack

Hospital group switches to manual processing systems which may lead to administrative delays

Ascendis succeeds in buying time to settle debts

Lenders give the drug maker 18 months to tame a debt burden that is 10 times its market cap

BL PREMIUM
Mediclinic scraps dividend because of pandemic

It is the first time in the 35-year history of SA’s biggest private hospital group that it has taken step

BL PREMIUM
Mediclinic loss almost doubles amid R10bn writedown

Private hospital group warns pandemic effects could last another 12 months

Netcare scraps its dividend for the first time since 1996

The private hospital group takes steps to preserve cash as Covid-19 storm batters the sector

BL PREMIUM
Covid-19 cost Netcare R143m in lost revenue in March

A plunge in hospital admissions weighed on income, the private hospital group says

Netcare warns investors of steep drop in earnings

Netcare blames part of the fall in earnings on changes in accounting standards

AstraZeneca’s quest for Covid-19 vaccine gets $1bn boost from US

However, there has been concern that the US could have a vaccine before other countries thanks to its funding of big pharmaceutical firms

WATCH: Why Dis-Chem withheld its dividend

Dis-Chem CFO Rui Morais and Advanced Health CEO Gerhard van Emmenis talk to Business Day TV

Moderna surges after experimental vaccine shows early promise

The shares jump 30% after the biotech company reports promising results from first study

Aspen Pharmacare maintains profit forecast

The Covid-19 pandemic has boosted demand for some of the drug maker’s products, although the pandemic’s effect in China has had a bad effect

Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.